Akari Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $25 | $0 | $0 |
Gross Profit | 12 | |||
EBITDA | -1,845 | -3,650 | -4,513 | |
EBIT | -3,119 | -3,648 | -4,295 | -2,949 |
Net Income | -1,895 | -3,705 | -3,772 | -2,895 |
Net Change In Cash | 0 | 25 | 0 | 0 |
Free Cash Flow | -3,256 | -2,150 | -2,124 | -1,490 |
Cash | 2,711 | 2,582 | 2,599 | 2,246 |
Basic Shares | 15 | 53,186,919 | 12 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -13 | -4 | -3 | -4 |
EBITDA | -21,643 | -16,802 | -23,084 | -17,210 |
EBIT | -20,035 | -16,806 | -23,087 | -17,214 |
Net Income | -19,791 | -10,008 | -6,972 | -17,606 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,552 | -16,432 | -21,504 | -18,846 |
Cash | 2,599 | 3,845 | 13,249 | 9,361 |
Basic Shares | 11 | 4 | 3 | 2 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.06 |
2025-03-31 | -$0.19 |
2024-09-30 | -$0.23 |
2024-06-30 | -$0.80 |
